The Cesarean Section Thromboprophylaxis Pilot Study:A Randomized Open-Label Controlled Pilot Study of Prophylactic Low Molecular Weight Heparin in High Risk Postpartum Women Following Cesarean Section.
Phase of Trial: Phase II/III
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Tinzaparin sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Therapeutic Use
- Acronyms STOP-CLOT
- 14 Jul 2009 Additional lead trial centre (LEO Pharma) and investigator (Marc Rodger) identified as reported by ClinicalTrials.gov.
- 03 Oct 2006 Status change
- 26 Nov 2005 New trial record.